Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Consumer Genomics Market reach $4.38 billion by 2031 Globally, at a CAGR of 19.9%, says Coherent Market Insights

This image opens in the lightbox

News provided by

Coherent Market Insights

17 Jan, 2024, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

BURLINGAME, Calif., Jan. 17, 2024 /PRNewswire/ -- The Consumer Genomics Market is projected to grow from US$ 1.23 billion in 2023 and is estimated to reach US$ 4.38 billion by 2031; it is expected to grow at a Compound Annual Growth Rate (CAGR) of 19.9% from 2024 to 2031 according to a new report by Coherent Market Insights. Consumer genomics is an upcoming field that analyzes DNA to provide health, ancestry and other personal information directly to consumers. It involves testing of genetic variations that may impact health and disease risk.

Request Sample of the Report: https://www.coherentmarketinsights.com/insight/request-sample/6547 

An increasing adoption of inorganic growth strategies such as acquisition by the key players in the market is expected to drive the growth of the market over the forecast period. For instance, in September 2021, Invitae Corp., a medical genetics company, announced the acquisition of Ciitizen, a consumer health technology company. This acquisition will expand the consumer genomics product portfolio of Invitae Corp.

Market Dynamics:

The consumer genomics market is expected to witness significant growth over the forecast period owing to rising awareness about personalized medicines and growing demand for direct-to-consumer genetic testing. The advent of direct-to-consumer genetic testing kits that provide health, wellness and ancestry related information directly to customers without involving a physician is fueling market growth. Customers find these genetic tests convenient as they provide health insights from the comfort of their home. Furthermore, advancements in DNA sequencing technologies have made genetic testing more affordable and accessible to mainstream customers interested in understanding their genetic makeup. This is another factor driving growth of the consumer genomics market.

Consumer Genomics Market Report Scope:

Report Coverage

Details

Market Revenue in 2023

$1.23 billion

Estimated Value by 2031

$4.38 billion

Growth Rate

Poised to grow at a CAGR of 19.9%

Historical Data

2017–2021

Forecast Period

2024–2031

Forecast Units

Value (USD Million/Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Product and Services, By Application

Geographies Covered

North America, Europe, Asia Pacific, and Rest of World

Restraints & Challenges

• Accuracy and reliability concerns

• Regulatory issues

Growth Drivers

• Rising Interest in Personalized Healthcare

• Advancing Technology

• Increasing product launch

• Falling Cost of Genomic Sequencing

The increasing adoption of personalized medicine approaches is a major driver for the growth of the consumer genomics market. Personalized medicine uses a person's genetic makeup and biomarkers to customize disease treatment, disease prevention strategies, and health management. It helps deliver the right treatment to the right patient at the right time. The benefits of personalized medicine such as improved outcomes, reduced drug toxicity, cost savings, and disease prevention are fueling its rising popularity. As consumer genomics provides genetic insights and interpretations that aid personalized medicine, its adoption is growing along with the rise of personalized healthcare.

Buy now this Business Complete Report: https://www.coherentmarketinsights.com/insight/buy-now/6547 

Market Key Developments:

On December 6, 2023, Imaware, a molecular diagnostics and consumer testing company, announced the acquisition of Binx Health's at-home consumer testing business. Binx Health is a molecular point-of-care testing platform designed to enable single-visit diagnosis and treatment of chlamydia and gonorrhea infections. The acquisition will expand Imaware's test menu and its position in the growing home-health testing market, as well as broaden the number of enterprise clients Imaware serves.

In October 2022, GC LabTech, a subsidiary of GC Biopharma of South Korea, launched a partnership with 1health.io, a health platform that connects clinicians and patients to labs, to deploy innovative lab tests direct-to-consumer.

In August 2021, Genetic Technologies Limited, a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment, announced the acquisition of EasyDNA, a leading DNA testing company.

Market Key Takeaways:

The global consumer genomics market is expected to exhibit a CAGR of 19.9% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global consumer genomics market.

Among products and services, the consumables segment is expected to hold a dominant position in the global consumer genomics market during the forecast period. Consumables contribute the highest share in the market due to increasing demand for testing kits and reagents from consumers and laboratories. According to reports from the National Institutes of Health, sales of direct-to-consumer genetic testing kits have increased exponentially over the past 5 years as more people become curious about their ancestry, genetic health risks, and traits. Many companies are offering affordable kits that allow consumers to collect DNA samples from home and send them to a lab for processing. This has led to rising consumption of products like sample collection tubes, assays, and other consumables used in DNA extraction and analysis.

Among regions, North America is expected to be the dominant region in the global consumer genomics market, owing to the increasing product launches by key players in the market. For instance, in August 2020, Ancestry, a consumer genomic company, announced the launch of a new product that features next-generation sequencing. The new product aims to help customers gain insights into their health and risk factors.

Major players operating in the global consumer genomics market are Ancestry, Gene By Gene, Ltd., 23andMe,Inc., Color Genomics,Inc, Myriad Genetics,Inc, Mapmygenome, Positive Biosciences, Ltd, Futura Genetics, Helix OpCo LLC, MyHeritage Ltd., Pathway Genomics, Veritas, Amgen, Inc., Xcode Life, Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., inui Health, AgeCurve, QuickCheck Health, Biomeb, Metabolomic Discoveries GmbH, Illumina, Inc., Genetic Technologies Limited.

Read complete market research report, "Consumer Genomics Market, By Product and Services, By Application, By Geography, Market Size And Share Analysis - Growth Trends And Forecasts 2024-2031", Published by Coherent Market Insights.

The falling cost of DNA sequencing and genetic testing is another key factor propelling the consumer genomics market growth. Earlier, whole genome sequencing used to cost millions of dollars and was limited to research only. However, advanced sequencing technologies have drastically lowered the cost to around $1000 now, making genetic testing affordable for general consumers. Several direct-to-consumer genetic testing companies are offering genetic testing kits and services at competitive prices, making them affordable for a wider consumer base. The reducing cost of testing is encouraging more people to access consumer genomics services and accordingly driving the market expansion.

Inadequate standards for interpreting genomic data is a major challenge restraining the growth of the consumer genomics market. Genomic data interpretation is a complex process and requires expertise from trained medical geneticists and genetic counselors. However, most DTC genetic testing companies do not have adequate genetic counselors or professionals to accurately interpret raw genetic data and explain results to consumers. This ambiguity in result interpretation can mislead consumers regarding disease risks or make them anxious unnecessarily. The lack of universal standards for genomic data interpretation increases the prevalence of inaccurate or erroneous results, which is slowing down the adoption of consumer genomics products and services.

Market Opportunities:

The rapid rise in chronic non-communicable diseases worldwide presents a huge opportunity for the growth of the consumer genomics market. Chronic diseases such as cancer, heart disease, diabetes are rapidly increasing due to lifestyle changes, growing geriatric population, and environmental factors. Consumer genomics can help identify disease risks, detect diseases at an early stage, predict drug responses, and enable disease prevention and management through early screening and intervention. As chronic diseases contribute significantly to healthcare costs, demand for consumer genomics from both individuals and healthcare providers is expected to grow tremendously in the coming years with rising chronic disease incidence rates.

Personalized nutrition using genetic insights is emerging as a major trend in the consumer genomics market. Genetic tests can provide consumers with a detailed analysis of their metabolism, nutrient absorption capabilities, nutrient deficiencies/sensitivities, food intolerances, and ideal macronutrient ratios. Based on these biological insights, personalized diet and supplement recommendations better suited to one's genetics are given. This helps optimize nourishment, address risk factors, and improve health and wellbeing. An increasing number of companies now offer personalized nutrition services in addition to ancestry and health reports. This trend is expected to gain more traction as consumers realize the benefits of tailoring their nutrition based on their unique genetic.

Ask for Customization: https://www.coherentmarketinsights.com/insight/request-customization/6547 

Detailed Segmentation:

Global Consumer Genomics Market Segmentation, By Product and Services:

  • Consumables
  • Systems
  • Software

Global Consumer Genomics Market Segmentation, By Application:

  • Diagnostics
  • Wellness and Nutrition
  • Personalized Medicine
  • Ancestry
  • Others    

Global Consumer Genomics Market Segmentation, By Region:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Find more related trending reports below:

Protein Sequencing Market, By Technology (Edman Degradation, Mass Spectrometry, Others), By Product (Instruments, Reagents, Kits & Consumables, Software & Services), By Application (Academic Research, Clinical Diagnosis, Biopharmaceuticals, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Occupational Health Market, By Service Type (Healthcare services, Drug & Alcohol Testing Services, Physical Examination Services, Disease Screening Services, Health Risk Assessment Services, Others), By Site Location (On-site, Off-site, Telehealth Services), By End User (Small size enterprises, Mid-size enterprise, Large enterprises), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Modal title

Also from this source

Global Cardiovascular Health Supplements Market worth $16.06 billion by 2030, Exclusive Report by Coherent Market Insights

Global Cardiovascular Health Supplements Market worth $16.06 billion by 2030, Exclusive Report by Coherent Market Insights

The global Cardiovascular Health Supplements Market is estimated to be valued at US$ 9.85 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over...

Global Glucose Biosensor Market Size to hit $21.3 billion by 2031, growing at a CAGR of 7.7%, says Coherent Market Insights

Global Glucose Biosensor Market Size to hit $21.3 billion by 2031, growing at a CAGR of 7.7%, says Coherent Market Insights

The global Glucose Biosensor Market is projected to grow from USD 11.77 billion in 2023 to USD 21.3 billion by 2031, with a compound annual growth...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.